Evaxion A/S (EVAX)
NASDAQ: EVAX · Real-Time Price · USD
3.090
-0.050 (-1.59%)
At close: Jun 26, 2026, 4:00 PM EDT
3.500
+0.410 (13.27%)
After-hours: Jun 26, 2026, 5:14 PM EDT
Evaxion Employees
Evaxion had 46 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
46
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$163,652
Profits / Employee
-$212,087
Market Cap
25.77M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 46 | 0 | - |
| Dec 31, 2024 | 46 | -3 | -6.12% |
| Dec 31, 2023 | 49 | -14 | -22.22% |
| Dec 31, 2022 | 63 | 2 | 3.28% |
| Dec 31, 2021 | 61 | 26 | 74.29% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| IGC Pharma | 70 |
| Vistagen Therapeutics | 41 |
| Plus Therapeutics | 28 |
| NeuroSense Therapeutics | 17 |
| Quantum BioPharma | 17 |
| BriaCell Therapeutics | 16 |
| Serina Therapeutics | 16 |
| Barinthus Biotherapeutics | 14 |
EVAX News
- 16 days ago - Evaxion receives Prix Galien UK Award for Best digital health solution - GlobeNewsWire
- 17 days ago - Evaxion presents new preclinical data for EVX-04, an off-the-shelf therapeutic vaccine for acute myeloid leukemia - GlobeNewsWire
- 6 weeks ago - Evaxion to present new data for EVX-04, an off-the-shelf therapeutic vaccine for acute myeloid leukemia, at the EHA 2026 Congress - GlobeNewsWire
- 7 weeks ago - Evaxion Earnings Call Transcript: Q1 2026 - Transcripts
- 7 weeks ago - Evaxion Earnings release: Q1 2026 - Filings
- 7 weeks ago - Evaxion Slides: Q1 2026 - Filings
- 7 weeks ago - Evaxion announces business update and first quarter 2026 financial results - GlobeNewsWire
- 7 weeks ago - Evaxion to announce business update and first quarter 2026 financial results on May 7, 2026 - GlobeNewsWire